According to a CBS News report, researchers at Los Angeles Biomedical Research Institute at UCLA Medical Center have announced the development of a promising new male contraceptive gel.
According to the report, the new gel contains the male hormone testosterone and a progestin called Nesterone. Progestin is a synthetic hormone that mimics the female hormone progesterone and increases the contraceptive effectiveness of testosterone in men.
But a report by KHOU out of ...
continue reading...
The federal Food and Drug Administration has unveiled a plan to track high-risk medical devices.
A Wall Street Journal report on the policy says that it would require the high-risk devices to carry identification numbers. Jeffrey Shuren, director of the FDA’s medical-device center, described the plan as “a major game-changer” and said the agency plans to ramp up efforts to identify malfunctioning medical devices early.
For a long time, public safety advocates ...
continue reading...
Members of a U.S. Food and Drug Administration panel that recently discussed metal-on-metal artificial hip implants said they wouldn’t recommend that patients get them, although the FDA as a whole has so far stopped short of an official ruling on the devices.
Still, the FDA Website has a section advising orthopedic surgeons who are performing metal-on-metal hip implantation surgery. And the FDA’s recommendations clearly reflect concerns about the devices shedding toxic ...
continue reading...
The $3 billion fine recently leveled against GlaxoSmithKline is the largest settlement ever involving a pharmaceutical company. But in light of the enormous profits that the British pharmaceutical giant brings in, some critics wonder whether even that will be enough to dissuade companies from engaging in dangerous fraud.
GlaxoSmithKline pleaded guilty to marketing drugs for unapproved uses, according to a New York Times report. Among the charges is that the company ...
continue reading...
A higher price as a selling point may seem counterintuitive. Why would somebody purchase a product specifically because it costs more, particularly if safer alternatives are available?
But according to an article by the National Research Center for Women and Families, that’s precisely what happened with Bayer’s Yasmin line of birth control pills, which includes read more.... --> continue reading...
In a piece for the Wall Street Journal, writer Katherine Sharpe argues that antidepressants are overprescribed in the United States, and discusses the challenges that face a growing segment of population – young people who have no conception of who they are when they aren’t on antidepressants.
She cites figures from the National Center for Health Statistics, which state that 5 percent of American 12- to 19-year-olds use antidepressants, and another ...
continue reading...
